Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berrie Meijer

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Therapeutic Drug Monitoring|October 18, 2017
Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel DiseaseMelek Simsek, Berrie Meijer, Chris J J Mulder, et al.
Inflammatory Bowel Diseases|March 5, 2015
Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remissionJames D Falvey, Teagan Hoskin, Berrie Meijer, et al.
Drug Discovery Today|September 5, 2017
Finding hidden treasures in old drugs: the challenges and importance of licensing genericsMelek Simsek, Berrie Meijer, Adriaan A van Bodegraven, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmissionAmarylle S van Doorn, Berrie Meijer, Chris M A Frampton, et al.
Journal of Crohn'S & Colitis|December 3, 2013
Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBDBerrie Meijer, Teagan Hoskin, Anna Ashcroft, et al.
Gut|June 28, 2023
Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel diseaseNanne K H de Boer, Melek Simsek, Berrie Meijer, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2019
Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBDSara van Gennep, Kadère Konté, Berrie Meijer, et al.
Therapeutic Drug Monitoring|May 11, 2017
Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database StudyBerrie Meijer, Abraham J Wilhelm, Chris J J Mulder, et al.
Therapeutic Drug Monitoring|May 10, 2016
Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel DiseaseBerrie Meijer, Margien L Seinen, Niek N W Leijte, et al.
Inflammatory Bowel Diseases|June 16, 2017
Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?Berrie Meijer, Margien L Seinen, Remco van Egmond, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Therapeutic Drug Monitoring|October 18, 2017
Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel DiseaseMelek Simsek, Berrie Meijer, Chris J J Mulder, et al.
Inflammatory Bowel Diseases|March 5, 2015
Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remissionJames D Falvey, Teagan Hoskin, Berrie Meijer, et al.
Drug Discovery Today|September 5, 2017
Finding hidden treasures in old drugs: the challenges and importance of licensing genericsMelek Simsek, Berrie Meijer, Adriaan A van Bodegraven, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2020
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmissionAmarylle S van Doorn, Berrie Meijer, Chris M A Frampton, et al.
Journal of Crohn'S & Colitis|December 3, 2013
Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBDBerrie Meijer, Teagan Hoskin, Anna Ashcroft, et al.
Gut|June 28, 2023
Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel diseaseNanne K H de Boer, Melek Simsek, Berrie Meijer, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2019
Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBDSara van Gennep, Kadère Konté, Berrie Meijer, et al.
Therapeutic Drug Monitoring|May 11, 2017
Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database StudyBerrie Meijer, Abraham J Wilhelm, Chris J J Mulder, et al.
Therapeutic Drug Monitoring|May 10, 2016
Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel DiseaseBerrie Meijer, Margien L Seinen, Niek N W Leijte, et al.
Inflammatory Bowel Diseases|June 16, 2017
Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?Berrie Meijer, Margien L Seinen, Remco van Egmond, et al.
Pageof 3